期刊文献+

ABO血型不合干细胞移植患者红细胞“配合型输血”的临床研究 被引量:4

A Clinical Investigation of Matched Blood Transfusion in the Patients with Stem Cell Transplants of ABO Incompatibility
下载PDF
导出
摘要 目的研究ABO血型不合干细胞移植患者嵌合体期间红细胞"配合型输血"的特点。方法调取ABO血型不合患者25例,分析嵌合体血型特征,包括嵌合体期间患者红细胞表面抗原与血清抗体分布;分析"配合型输血",即嵌合体的红细胞输注方案;评价配血型输血疗效,分析输血反应。结果 25例干细胞移植ABO血型不合患者,根据嵌合体期间患者红细胞表面抗原与血清抗体分布选择红细胞"配合型输血",有效输血76.38%,嵌合体各组红细胞输注前后Hb差异均有统计学意义,不良反应3次,均为非溶血性发热反应。结论 ABO血型不合干细胞移植患者,嵌合体期间选择红细胞"配合型输血",可有效提高患者Hb水平,保证输血安全。 Objective To study the characteristics of the "matched blood transfusion" in the patients with stem cell transplants of ABO incompatibility.Methods Twenty five casesof ABO blood group incompatibility were detected for their blood group chimericcharacteristics,including the surface antigen of red blood cells (RBCs) and serum antibody alteration. Scheme of transfusion of chimericRBCs andthe effect and adverse reactions following transfusion were evaluated.Results Twenty five patients with stem cell transplants and ABO incompatibility received matched blood transfusion based on the surface antigen of RBCs and serum antibody alteration in chimera,and the transfusion efficacyof 76.38% was obtained. A significantly increased HB levelinpre- and post- transfusions was noted although 3 times of adverse reactions such as non-hemolytic febrile occurred. Conclusion The matched red blood cell transfusion in the patients with chimeric stem cell transplants and ABO incompatibility may help elevate the HB level and ensure the transfusion safety.
出处 《临床输血与检验》 CAS 2017年第4期352-354,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 ABO血型 嵌合体 造血干细胞移植 配合型输血 ABO blood group Chimeric Hematopoietic stem cell transplantation Compatible transfusion therapy
  • 相关文献

参考文献6

二级参考文献39

  • 1鲍立,黄晓军,刘开彦,许兰平,陈欢,张耀臣,陈育红,韩伟,陆道培.ABO血型不合对异基因造血干细胞移植的影响[J].北京大学学报(医学版),2005,37(2):126-129. 被引量:14
  • 2黄晓军,刘代红,许兰平,韩伟,江倩,陈育红,张耀臣,刘开彦,鲍立,陆道培.主要ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍[J].中华血液学杂志,2005,26(9):548-550. 被引量:26
  • 3郭永建,池泉.血小板输注与红细胞血型[J].中国输血杂志,2007,20(1):88-91. 被引量:5
  • 4Bucker CD,Clift RA,Sanders JE,et al, ABO- incompatible marrow transplants. Transplantation 1978; 26 (2) :233-238
  • 5Lee JH,Lee KH,Kim S,et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO- incompatible allogeneic bone marrow transplatation. Bone marrow Transplant 2000; 25 (2) :179-184
  • 6Klumpp TR, Herman JH, Ulicny J. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplant 2006;38(9):615-620
  • 7Mueller RJ,Stussi G,Odermatt B.Major ABO-incompatible hematooietic stem cell aplasia and endothelial cell chimerism. Xenotransplantation 2006;13 ( 1 ) :126-133
  • 8Stussi G,Huggel K,Lutz HU. lsotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol 2005;130 (6) :954-963
  • 9Oran B, Donato M, Aleman A.Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transplant 2007; 13(4):469-477
  • 10Martinez MT, Bucher Ch, Stussi G, et al, Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant. 2005;36(11):993-1000

共引文献152

同被引文献32

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部